MHC class I molecules
暂无分享,去创建一个
[1] B. Baker,et al. MHC Allele-Specific Molecular Features Determine Peptide/HLA-A2 Conformations That Are Recognized by HLA-A2-Restricted T Cell Receptors1 , 2002, The Journal of Immunology.
[2] Daniel Coombs,et al. Supplementary information for Activated TCRs remain marked for internalization after dissociation from pMHC , 2022 .
[3] F. Cainelli,et al. Infections and solid organ transplant rejection: a cause-and-effect relationship? , 2002, The Lancet. Infectious diseases.
[4] P. Moss,et al. Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals1 , 2002, The Journal of Immunology.
[5] R. Welsh,et al. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens , 2002, Nature Immunology.
[6] Raymond M. Welsh,et al. No one is naive: the significance of heterologous T-cell immunity , 2002, Nature Reviews Immunology.
[7] E. Petersdorf,et al. Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles. , 2002, Blood.
[8] D. Briscoe,et al. A rendezvous before rejection: Where do T cells meet transplant antigens? , 2002, Nature Medicine.
[9] M. Salmon,et al. EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function1 , 2001, The Journal of Immunology.
[10] V. Emery,et al. Viral infections and their impact on chronic renal allograft dysfunction. , 2001, Transplantation.
[11] P. Parham,et al. The Repertoire of Killer Cell Ig-Like Receptor and CD94:NKG2A Receptors in T Cells: Clones Sharing Identical αβ TCR Rearrangement Express Highly Diverse Killer Cell Ig-Like Receptor Patterns1 , 2001, The Journal of Immunology.
[12] J. Ortaldo,et al. The Virus-Specific and Allospecific Cytotoxic T-Lymphocyte Response to Lymphocytic Choriomeningitis Virus Is Modified in a Subpopulation of CD8+ T Cells Coexpressing the Inhibitory Major Histocompatibility Complex Class I Receptor Ly49G2 , 2000, Journal of Virology.
[13] R. Welsh,et al. Evolution of the CD8 T-cell repertoire during infections. , 2000, Microbes and infection.
[14] H. Rammensee,et al. The Role of Peptides in T Cell Alloreactivity Is Determined by Self–Major Histocompatibility Complex Molecules , 2000, The Journal of experimental medicine.
[15] D. Speiser,et al. In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes , 1999, The Journal of experimental medicine.
[16] S. L. Silins,et al. The influence of antiviral T-cell responses on the alloreactive repertoire. , 1999, Immunology today.
[17] S. Burrows,et al. Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonism. , 1999, Blood.
[18] P. Ljungman,et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis , 1998, Bone Marrow Transplantation.
[19] R. Germain,et al. Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. , 1998, Journal of immunology.
[20] R. Germain,et al. T-cell signaling: The importance of receptor clustering , 1997, Current Biology.
[21] V. Engelhard,et al. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides. , 1997, Transplantation.
[22] J. McCluskey,et al. Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivity , 1997, European journal of immunology.
[23] J. Burrows,et al. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.
[24] D. Wiley,et al. Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Bjorkman,et al. Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. , 1992, Science.
[26] Dean R. Madden,et al. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.
[27] D. Wiley,et al. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. Balderas,et al. T-cell receptor alpha-chain variable-region haplotypes of normal and autoimmune laboratory mouse strains. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Barnstable,et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.
[30] R. Lechler,et al. The molecular basis of alloreactivity. , 1990, Immunology today.
[31] F. Miedema,et al. Anti‐HLA‐class II monoclonal antibodies inhibit polyclonal B cell differentiation in vitro at the accessory cell level , 1987, European journal of immunology.